Sepio Capital, LP Novartis Ag Transaction History

Sepio Capital, LP

$1.03 Billion
Q3 2024

A detailed history of Sepio Capital, LP transactions in Novartis Ag stock. As of the latest transaction made, Sepio Capital, LP holds 13,687 shares of NVS stock, worth $1.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

13,687

Previous 13,820 0.96%

Holding current value

$1.41 Million

Previous $1.47 Million 7.0%

% of portfolio

0.15%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $14,115 - $16,078	-133 Reduced 0.96%	13,687 $1.57 Million
Q2 2024 Aug 15, 2024	SELL	$92.57 - $107.37 $2,962 - $3,435	-32 Reduced 0.23%	13,820 $1.47 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $119,754 - $136,346	-1,257 Reduced 8.32%	13,852 $1.34 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $191,091 - $210,289	-2,071 Reduced 12.05%	15,109 $1.53 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $88,951 - $98,717	939 Added 5.78%	17,180 $1.75 Million
Q2 2023 Aug 08, 2023	SELL	$92.52 - $104.91 $60,045 - $68,086	-649 Reduced 3.84%	16,241 $1.64 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $1.38 Million - $1.6 Million	-17,250 Reduced 50.53%	16,890 $1.55 Million
Q4 2022 Feb 03, 2023	SELL	$75.55 - $92.52 $922,314 - $1.13 Million	-12,208 Reduced 26.34%	34,140 $3.1 Million
Q3 2022 Oct 28, 2022	SELL	$74.61 - $87.26 $205,252 - $240,052	-2,751 Reduced 5.6%	46,348 $3.52 Million
Q2 2022 Jul 26, 2022	SELL	$80.52 - $93.75 $231,092 - $269,062	-2,870 Reduced 5.52%	49,099 $4.15 Million
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $456,867 - $516,805	-5,703 Reduced 9.89%	51,969 $4.56 Million
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $95,560 - $105,667	-1,199 Reduced 2.04%	57,672 $5.05 Million
Q3 2021 Nov 03, 2021	BUY	$81.78 - $95.14 $56,346 - $65,551	689 Added 1.18%	58,871 $4.81 Million
Q2 2021 Jul 26, 2021	SELL	$85.24 - $94.15 $124,706 - $137,741	-1,463 Reduced 2.45%	58,182 $5.31 Million
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $4.98 Million - $5.87 Million	59,645 New	59,645 $5.1 Million
Q3 2019 Oct 25, 2019	SELL	$85.54 - $94.26 $2.09 Million - $2.3 Million	-24,437 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $13,496 - $16,611	-179 Reduced 0.73%	24,437 $2.23 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $242,229 - $277,058	-3,216 Reduced 11.56%	24,616 $2.37 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $2.05 Million - $2.28 Million	27,832 New	27,832 $2.39 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Account